Fibroblast bioenergetics to classify amyotrophic lateral sclerosis patients.

Autor: Konrad C; Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, 407 East 61st Street, RR507, New York, NY, 10065, USA., Kawamata H; Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, 407 East 61st Street, RR507, New York, NY, 10065, USA., Bredvik KG; Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, 407 East 61st Street, RR507, New York, NY, 10065, USA., Arreguin AJ; Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, 407 East 61st Street, RR507, New York, NY, 10065, USA., Cajamarca SA; Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, 407 East 61st Street, RR507, New York, NY, 10065, USA., Hupf JC; Department of Neurology, Columbia University, New York, NY, USA., Ravits JM; Department of Neuroscience, University of California San Diego, La Jolla, CA, USA., Miller TM; Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA., Maragakis NJ; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Hales CM; Department of Neurology, Emory School of Medicine, Atlanta, GA, USA., Glass JD; Department of Neurology, Emory School of Medicine, Atlanta, GA, USA., Gross S; Department of Pharmacology, Weill Cornell Medicine, New York, NY, USA., Mitsumoto H; Department of Neurology, Columbia University, New York, NY, USA., Manfredi G; Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, 407 East 61st Street, RR507, New York, NY, 10065, USA. gim2004@med.cornell.edu.

Publikováno v: Molecular neurodegeneration [Mol Neurodegener] 2017 Oct 24; Vol. 12 (1), pp. 76. Date of Electronic Publication: 2017 Oct 24.